Trending News
News

News
Med BioGene Welcomes Renowned Expert to Lymphoma Collaboration
Med BioGene Inc. has welcomed Sandeep S. Dave, M.D. of Duke University to its lymphoma collaboration.

News
SRI International and Pentax Corporation Develop Biomarkers for Oncology Diagnostics
The ultimate goal of the collaboration is to develop medical diagnostic tools for therapeutic intervention in the treatment of cancer.

News
DxS Signs a License with DiagnoCure for its Scorpions® Technology
DiagnoCure will gain access to Scorpions for the development of their GCC-based molecular test for colorectal cancer.

News
IPSOGEN Grants Labcorp License for Leukemia Molecular Diagnostic Assay in USA
IPSOGEN grants LabCorp non-exclusive rights to offer an assay for the diagnosis of a group of leukemias caused by JAK2 gene variations.

News
Eden Biodesign and Borean Pharma Sign Deal to Develop Therapeutic Candidate for the Treatment of Cancer
Eden will manufacture MBP-DC-SIGN for Borean to use in key preclinical studies.

News
Increased Risk for Arthritis and Lupus Tied to new Gene
Scientists identify a critical gene that increases a person’s risk for rheumatoid arthritis and systemic lupus and may be involved in other autoimmune diseases.

News
Celera to Acquire Berkeley HeartLab
Acquisition provides Celera with CLIA-certified laboratory to commercialize its portfolio of new tests & vehicle to deliver personalized disease management in cardiovascular disease.

News
Philips and the Institute of Health Sciences Join Forces in Molecular Medicine
Royal Philips Electronics and IHS will create new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment.

News
Agendia Raises €25 Million and Receives Second FDA Clearance
ING, one of the largest bank-insurers, becomes a shareholder of Agendia.

News
Ipsogen Grants Exclusive License to Warnex to Market a Leukemia Molecular Diagnostic Service in Canada
Ipsogen grants Warnex exclusive rights to market a service for the diagnosis and the classification of a group of leukemias.
Advertisement